BridgeMD
New treatment option for Delivery Complication
Official title Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes
ClinicalTrials.gov ID: NCT06181396
What this study is testing
What is Oxytocin?
Oxytocin is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for delivery complication.
Also referred to as Pitocin.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Early oxytocin administration at the 2nd stage of labor is associated with a higher rate of vaginal delivery, shorter second stage duration, and fewer adverse maternal and neonatal outcomes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- Singleton pregnancy
- Maternal age ≥ 18 years' old
- Oxytocin administration initiated or renewed during second stage of labor
You likely can't join if
- Maternal age \< 18 years' old
- Multiple gestation pregnancy
- Known fetal malformations
- Uterine scar
The study team makes the final eligibility decision.
Where it's taking place
- Haifa, Israel
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Haifa, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.